Table 4. Effect of Duration of HAART on BMD.

	Duration on HAART at time of DEXA scan			total (n=181)	p (ANOVA)
	0-12 months (n=30)	13-18 months (n=12)	>18 months (n=139)
SpineHologic BMD	0.97596667 ±0.17664878	0.93491667 ±0.11031645	0.9961223 ±0.14194909	0.98872376 ±0.1465658	0.3349
HipHologic BMD	0.9622 ±0.16673423	0.92508333 ±0.11881495	0.95506475 ±0.12778153	0.95425967 ±0.13389409	0.7139
Femoral Neck Hologic BMD	0.8306 ±0.13838716	0.78941667 ±0.10627191	0.81756115 ±0.1351834	0.81785635 ±0.13366809	0.6672

BMD measures are shown as mean± standard deviation from the mean.

All BMD recorded as g/cm²

All individuals that had never been on HAART (n=41) were excluded from this analysis.

BMD: bone mineral density

HAART: highly active antiretroviral therapy